LSA
CORT icon

Leonteq Securities AG’s Corcept Therapeutics CORT Stock Holding History

Leonteq Securities AG’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6K Buy
+375
New +$22.6K ﹤0.01% 888
2025
Q3 		– Sell
-90
Closed -$6.61K – 1333
2025
Q2 		$6.61K Buy
+90
New +$6.53K ﹤0.01% 1108
2024
Q4 		– Sell
-200
Closed -$9.26K – 1279
2024
Q3 		$9.26K Buy
+200
New +$7.11K ﹤0.01% 987
2021
Q3 		– Sell
-1,100
Closed -$24.2K – 1145
2021
Q2 		$24.2K Buy
+1,100
New +$24.5K ﹤0.01% 924

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's CORT Position: Q2 2026 in Review

Leonteq Securities AG opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 375 shares worth $32.6K. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings. This is a return to the name: Leonteq Securities AG previously reported a position in CORT as recently as Q2 2025.

Leonteq Securities AG first reported a position in CORT in Q2 2021 and has held it in 4 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Leonteq Securities AG held 375 shares of Corcept Therapeutics worth $32.6K as of Q2 2026.
  • Corcept Therapeutics was a new Leonteq Securities AG position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #888 holding.
  • Leonteq Securities AG first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.